litlas
ログインアカウント作成

Franck Morschhauser

2001–2026 年に発表

236
論文数
29,441
被引用数
93
h 指数
218
i10 指数

被引用数

Franck Morschhauser の年別被引用数1993 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 6 件2004 年: 被引用 6 件2005 年: 被引用 24 件2006 年: 被引用 20 件2007 年: 被引用 36 件2008 年: 被引用 45 件2009 年: 被引用 50 件2010 年: 被引用 62 件2011 年: 被引用 90 件2012 年: 被引用 99 件2013 年: 被引用 101 件2014 年: 被引用 100 件2015 年: 被引用 152 件2016 年: 被引用 121 件2017 年: 被引用 148 件2018 年: 被引用 209 件2019 年: 被引用 726 件2020 年: 被引用 985 件2021 年: 被引用 1,049 件2022 年: 被引用 1,067 件2023 年: 被引用 1,017 件2024 年: 被引用 1,860 件2025 年: 被引用 976 件2026 年: 被引用 14 件1994〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,557 件、この内訳の 23.9%中国: 引用元論文 890 件、この内訳の 8.3%フランス: 引用元論文 790 件、この内訳の 7.4%ドイツ: 引用元論文 721 件、この内訳の 6.7%イギリス: 引用元論文 675 件、この内訳の 6.3%イタリア: 引用元論文 658 件、この内訳の 6.1%スイス: 引用元論文 409 件、この内訳の 3.8%スペイン: 引用元論文 398 件、この内訳の 3.7%カナダ: 引用元論文 372 件、この内訳の 3.5%オーストラリア: 引用元論文 332 件、この内訳の 3.1%オランダ: 引用元論文 291 件、この内訳の 2.7%日本: 引用元論文 244 件、この内訳の 2.3%
0%23.9%その他 22.2%

機関

分野

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology3.9%
  • Chemistry0.3%
  • Computer Science0.3%
  • Neuroscience0.2%
  • その他0.7%

トピック

  • Lymphoma Diagnosis and Treatment17.3%
  • CAR-T cell therapy research9.3%
  • Chronic Lymphocytic Leukemia Research6.5%
  • Viral-associated cancers and disorders4.4%
  • CNS Lymphoma Diagnosis and Treatment4.3%
  • Monoclonal and Polyclonal Antibodies Research2.6%
  • その他55.6%

共著者

全論文

検索で開く
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  2. Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    著者: Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang‐Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Pérez-Callejo, Linda Lundberg, James Relf, Mark R. Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings - New England Journal of Medicine 2022 被引用: 676

  3. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

    著者: Manali Kamdar, Scott R. Solomon, Jon Arnason, Patrick B. Johnston, Bertram Glaß, Veronika Bachanová, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco J. Hernandez‐Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, David G. Maloney, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Lara Stepan, K. OGASAWARA, Timothy R. Mack, Jeremy S Abramson - The Lancet 2022 被引用: 752

  4. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

    著者: Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan M. Bergua-Burgués, Matthew C. Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles - New England Journal of Medicine 2021 被引用: 843

  5. Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study

    著者: Jeremy S. Abramson, Scott R. Solomon, Jon Arnason, Patrick B. Johnston, Bertram Glaß, Veronika Bachanová, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco J. Hernandez‐Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, K. OGASAWARA, Manali Kamdar - Blood 2022 被引用: 368

  6. A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

    著者: Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau, Olivier Hermine, Thomas Gastinne, Jean‐Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thiéblemont, Roch Houot, Franck Morschhauser - Nature Medicine 2022 被引用: 383

  7. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

    著者: Michael R. Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian W. Flinn, Werner Rabitsch, Yok‐Lam Kwong, Marie José Kersten, Monique C. Minnema, Harald Holte, Esther Hian Li Chan, Joaquín Martínez‐López, Antonia Müller, Richard T. Maziarz, Joseph P. McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David A. Bond, Charalambos Andreadis, Peter A. McSweeney, Mohamed A. Kharfan‐Dabaja, Simon Newsome, Evgeny Degtyarev, Rakesh Awasthi, Christopher del Corral, Giovanna Andreola, Aisha Masood, Stephen J. Schuster, Ulrich Jäger, Peter Borchmann, Jason R. Westin - New England Journal of Medicine 2021 被引用: 520

  8. Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

    著者: Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos, Pam McKay, Tycel Phillips, Sarit Assouline, Connie Lee Batlevi, Phillip L. Campbell, Vincent Ribrag, Gandhi Damaj, Michael Dickinson, Wojciech Jurczak, Maciej Kazmierczak, Stephen Opat, John Radford, Anna Schmitt, Jay Yang, Jennifer Whalen, Shefali Agarwal, Deyaa Adib, Gilles Salles - The Lancet Oncology 2020 被引用: 587

  9. Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

    著者: Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmelo Carlo‐Stella, Fritz Offner, Anna Sureda, Gilles Salles, Joaquín Martínez‐López, Michael Crump, Denise Thomas, Peter N. Morcos, Cristiano Ferlini, Ann-Marie E Bröske, Anton Belousov, Marina Bacac, Natalie Dimier, David Carlile, Linda Lundberg, David Pérez-Callejo, Pablo Umaña, Tom Moore, Maja Weisser, Michael Dickinson - Journal of Clinical Oncology 2021 被引用: 413

  10. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    著者: Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, Tim Illidge, Michelle A. Fanale, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo‐Doménech, Giuseppe Rossi, Won Seog Kim, Tatyana Feldman, Anne Lennard, David Belada, Árpád Illés, Kensei Tobinai, Kunihiro Tsukasaki, Su‐Peng Yeh, Andrei R. Shustov, Andreas Hüttmann, Kerry J. Savage, Sam Yuen, Swaminathan P. Iyer, Pier Luigi Zinzani, Zhaowei Hua, Meredith Little, Shangbang Rao, Joseph Woolery, Thomas Manley, Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski ほか 69 名 - The Lancet 2018 被引用: 726

  11. Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

    著者: Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François‐Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Olivier Casasnovas, Jacques Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean‐Jacques Tudesq, Laëtitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thiéblemont - Blood 2022 被引用: 148

  12. Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

    著者: Emmanuel Bachy, Vincent Camus, Catherine Thiéblemont, David Sibon, Olivier Casasnovas, Loïc Ysebaert, Gandhi Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc André, Alejandro Martı́n, María Jesús Peñarrubia, Philipp B. Staber, Judith Trotman, Andreas Hüttmann, Vittorio Stefoni, Alessandro Re, Philippe Gaulard, Marie‐Hélène Delfau‐Larue, Laurence de Leval, Michel Meignan, Ju Li, Franck Morschhauser, Richard Delarue - Journal of Clinical Oncology 2021 被引用: 192

  13. Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

    著者: Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba, Alejandro Martı́n, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad S. Kahl, Hervé Ghesquières, Kirit M. Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan P Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia A. Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J. Nastoupil - Nature Medicine 2024 被引用: 130

  14. Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

    著者: Bertrand Coiffier, Barbara Pro, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm, Lauren Pinter‐Brown, Swaminathan P. Iyer, Andrei R. Shustov, Jean Nichols, Susan Carroll, John Balser, Barbara Balser, Sarah McCue Horwitz - Journal of Clinical Oncology 2012 被引用: 674

  15. Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    著者: Maria Corinna Palanca-Wessels, Myron S. Czuczman, Gilles Salles, Sarit Assouline, Laurie H. Sehn, Ian W. Flinn, Manish R. Patel, Randeep Sangha, Anton Hagenbeek, Ranjana H. Advani, Hervé Tilly, Olivier Casasnovas, Oliver W. Press, Sreeni Yalamanchili, Robert S. Kahn, Randall Dere, Dan Lü, Surai Jones, Cheryl Jones, Yu-Waye Chu, Franck Morschhauser - The Lancet Oncology 2015 被引用: 335

  16. Management and outcome of primary CNS lymphoma in the modern era

    著者: Caroline Houillier, Carole Soussain, Hervé Ghesquières, Pierre Soubeyran, Olivier Chinot, Luc Taillandier, T. Lamy, Sylvain Choquet, Guido Ahle, Gandhi Damaj, Philippe Agapé, Cécile Moluçon‐Chabrot, Alexandra Amiel, Vincent Delwail, Michel Fabbro, Fabrice Jardin, Adrien Chauchet, Marie‐Pierre Moles‐Moreau, Franck Morschhauser, Olivier Casasnovas, Rémy Gressin, Luc‐Matthieu Fornecker, Julie Abraham, Jean‐Pierre Marolleau, Adrian Tempescul, Chantal Campello, Philippe Colin, Jérôme Tamburini, Kamel Laribi, Caroline Serrier, Corinne Haïoun, Safia Chebrek, Anna Schmitt, Marie Blonski, Roch Houot, Eileen M. Boyle, Jacques‐Olivier Bay, Lucie Obéric, Émeline Tabouret, Agathe Waultier, N. Martin–Duverneuil, Valérie Touitou, Nathalie Cassoux, Aurélie Kas, Karima Mokhtari, Frédéric Charlotte, Agustí Alentorn, L. Feuvret, Magali Le Garff‐Tavernier, Myrto Costopoulos, Bertrand Mathon, Matthieu Peyre, Daniel Delgadillo, Hassen Douzane, Diane Genet, Bachir Aidaoui, Khê Hoang‐Xuan, Emmanuel Gyan - Neurology 2020 被引用: 245

  17. Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

    著者: Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie‐Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Olivier Casasnovas, Magalie Joris, Cristina Castilla‐Llorente, Corinne Haïoun, Olivier Hermine, Michaël Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thiéblemont, Roch Houot - Blood Advances 2023 被引用: 77

  18. Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

    著者: Michael Wang, Simon Rule, Pier Luigi Zinzani, André Goy, Olivier Casasnovas, Stephen D. Smith, Gandhi Damaj, Jeanette K. Doorduijn, T. Lamy, Franck Morschhauser, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis, Eric D. Jacobsen, Arnon P. Kater, Steven Le Gouill, Lucie Obéric, Tadeusz Robak, Todd Covey, Richa Dua, Ahmed Hamdy, Xin Huang, Raquel Izumi, Priti Patel, Wayne Rothbaum, J. Greg Slatter, Wojciech Jurczak - The Lancet 2017 被引用: 448

  19. Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

    著者: Roch Houot, Emmanuel Bachy, Guillaume Cartron, François‐Xavier Gros, Franck Morschhauser, Lucie Obéric, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thiéblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques‐Olivier Bay, Francisco Llamas Gutierrez, Cédric Menard, Karin Tarte, Marie-Hélène Delfau, Cédric Portugues, Emmanuel Itti, Xavier Palard-Novello, Paul Blanc‐Durand, Yassine Al Tabaa, Clément Bailly, Camille Laurent, François Lemonnier - Nature Medicine 2023 被引用: 90

  20. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    著者: Sandy Amorim, Anastasios Stathis, Mary Gleeson, Sunil Iyengar, Valeria Magarotto, Xavier Leleu, Franck Morschhauser, Lionel Karlin, Florence Broussais, Keyvan Rezaï, Patrice Herait, Carmen Kahatt, François Lokiec, Gilles Salles, Thierry Façon, Antonio Palumbo, David Cunningham, Emanuele Zucca, Catherine Thiéblemont - The Lancet Haematology 2016 被引用: 428

  21. Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

    著者: Martin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George Follows, Georg Lenz, Won Seog Kim, Arnon Nagler, Panayiotis Panayiotidis, Judit Demeter, Muhıt Özcan, Marina Kosinova, Krimo Bouabdallah, Franck Morschhauser, Don A. Stevens, David R. Trevarthen, Marius Giurescu, Lisa Cupit, Li Liu, Karl Köchert, Henrik Seidel, Carol E. Peña, Shuxin Yin, Florian Hiemeyer, J. Garcia‐Vargas, Barrett H. Childs, Pier Luigi Zinzani - Journal of Clinical Oncology 2017 被引用: 398

  22. Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

    著者: Franck Morschhauser, Ian W. Flinn, Ranjana H. Advani, Laurie H. Sehn, Catherine Diefenbach, Kathryn S. Kolibaba, Oliver W. Press, Gilles Salles, Hervé Tilly, Andy I. Chen, Sarit Assouline, Bruce D. Cheson, Martin Dreyling, Anton Hagenbeek, Pier Luigi Zinzani, Surai Jones, Ji Cheng, Dan Lü, Elicia Penuel, Jamie Hirata, Michael Wenger, Yu-Waye Chu, Jeff P. Sharman - The Lancet Haematology 2019 被引用: 249

  23. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    著者: Franck Morschhauser, Nathan Fowler, Pierre Feugier, Réda Bouabdallah, Hervé Tilly, M. Lia Palomba, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Nicolas Daguindau, Steven Le Gouill, Gian M. Pica, Alejandro Martı́n, Armando López‐Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Pierre Zachée, Laurie H. Sehn, Kensei Tobinai, Guillaume Cartron, David Liu, Jianming Wang, Luc Xerri, Gilles Salles - New England Journal of Medicine 2018 被引用: 362

  24. A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

    著者: Franck Morschhauser, Pierre Feugier, Ian W. Flinn, Robin Gasiorowski, Richard Greil, Árpád Illés, Nathalie A. Johnson, Jean-François Larouche, Pieternella J. Lugtenburg, Caterina Patti, Gilles Salles, Marek Trněný, Sven de Vos, Farheen Mir, Divya Samineni, Su Y. Kim, Yanwen Jiang, Elizabeth A. Punnoose, Arijit Sinha, Emma Clark, Nathalie Spielewoy, Kathryn Humphrey, Alexandra Bazeos, Andrew D. Zelenetz - Blood 2020 被引用: 169